Back To Schedule
Tuesday, March 14 • 3:30pm - 4:00pm
Case Study: Harbour BioMed-- Technology Platform Value Maximization

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.
  • A look at the history of our company as a technology platform
  • Examining the value proposition, creation, and realization (PCR) at Harbour
  • Value proposition: early validation via several technology licenses with big pharma
  • Value creation: how we build an asset portfolio to further showcase our platform
  • Value realization: creating asset licenses with big pharma to realize the value of these assets
  • Value expansion: platform, plus discovery platform established as an independent entity

avatar for Weihao Xu

Weihao Xu

Chief Financial Officer & Chief Business Officer, Harbour BioMed
Mr. Weihao Xu, is Chief Financial Officer and Chief Business Officer at Harbour BioMed, a global, clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics in the areas of oncology and immunological diseases... Read More →

Tuesday March 14, 2023 3:30pm - 4:00pm PDT
Hyatt Centric Fisherman's Wharf San Francisco